Jazz Pharmaceuticals (JAZZ) Tax Provisions (2012 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Tax Provisions of $6.1 million for Q1 2026, up 134.27% year-over-year from $2.6 million in Q1 2025, and up 23.06% quarter-over-quarter from $5.0 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Tax Provisions (2012 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Tax Provisions history runs 15 years deep, the most recent figure standing at $6.1 million for Q1 2026.
- In Q1 2026, Tax Provisions rose 134.27% year-over-year to $6.1 million; the TTM figure through Mar 2026 stood at -$248.5 million (down 105.47% YoY), while the FY2025 annual figure was -$272.4 million, down 197.98% from the prior year.
- Tax Provisions for Q1 2026 stood at $6.1 million, up from $5.0 million in the prior quarter.
- The five-year high for Tax Provisions was $11.7 million in Q1 2024, with the low at -$242.4 million in Q3 2025.
- The 5-year median for Tax Provisions is -$17.8 million (2025), against an average of -$37.4 million.
- The sharpest annual moves came in 2023 and 2024: Tax Provisions sank 2958.96% in 2023, then jumped 176.15% in 2024.
- Jazz Pharmaceuticals' Tax Provisions stood at -$100.0 million in 2022, then jumped by 66.91% to -$33.1 million in 2023, then plunged by 75.01% to -$57.9 million in 2024, then jumped by 108.56% to $5.0 million in 2025, then advanced by 23.06% to $6.1 million in 2026.
- Business Quant data shows JAZZ's Tax Provisions at $6.1 million in Q1 2026, $5.0 million in Q4 2025, and -$242.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 18.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.10 Mn |
| Mar 31, 2026 | 6.10 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | -242.40 Mn |
| Jun 30, 2025 | -17.20 Mn |
| Mar 31, 2025 | -17.80 Mn |
| Dec 31, 2024 | -57.93 Mn |
| Sep 30, 2024 | -14.53 Mn |
| Jun 30, 2024 | -30.70 Mn |
| Mar 31, 2024 | 11.67 Mn |
| Dec 31, 2023 | -33.10 Mn |
| Sep 30, 2023 | -47.20 Mn |
| Jun 30, 2023 | -24.30 Mn |
| Mar 31, 2023 | -15.32 Mn |
| Dec 31, 2022 | -100.04 Mn |
| Sep 30, 2022 | -43.00 Mn |
| Jun 30, 2022 | -16.10 Mn |
| Mar 31, 2022 | 536,000.00 |
| Dec 31, 2021 | -12.47 Mn |
| Sep 30, 2021 | -18.10 Mn |